The Kush Report

 

 Video Reconsideration Please [13:08m]: Play Now | Play in Popup | Download

Our post election and post Breast Cancer Awareness Month podcast finds Kush Co. LLC founder and CEO Cathinka Chandler having voted in her second election as a US Citizen! It was only four years ago that she gained her dual Dutch and US citizenship … and began participating in our democratic process.

Although the Breast Cancer Awareness Month has passed, we are still strongly in support of raising awareness and funds for the fight, but we thought we would turn our attentions back to the challenges that face a new product in the marketplace. We have the particular challenge of trying to promote a product that has a lack of awareness regarding the type of product that it is.

We produced a new video ad with the intention of targeting the very specific market of women who have had breast augmentations.  The ad shows in a very tasteful way how the product is used, features a testimonial from an actual user of the product and we believe speaks to the benefits of support, comfort, and stress relief to the user. The ad can be seen in the left hand column of the blog or on YouTube.

Upon submitting the video to Google, and choosing the content network placements that we felt were most appropriate for the types of customers we are looking to contact … a rejection notice came for both the initial submission and a request for reconsideration.

The rejection was based upon the editorial guidelines that placed it into a category of sexually themed content.  Viewing the video and recognizing the medical benefits of the product, combined with the fact that we are picking very specific types of sites for the ad to appear, thought this would overcome this particular obstacle.

Tell us what you think!  View the video and leave a response in the episode comment section of the site.  Are we representing the product well and in a tasteful manner?  We would love to have your comments.

You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.